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Summary
Objective: The aim was to report the results of the ﬁrst case in France of pediatric auditory
rehabilitation with a middle ear implant and to discuss the putative indications with this new
therapeutic option in children.
Patient and methods: A prospective study over 18months on clinical and audiometric results
after a middle ear implantation with a Vibrant Med-El® implant in a 9-year-old child with mixed
hearing loss.
Results: Postoperative unaided pure tone audiometry (PTA) was unchanged by the surgical pro-
cedure. After 18months of implant use, the mean PTA loss in free-ﬁeld warble tone audiometry
was 33.75 dB and the intelligibility threshold was 30 dB. After 18months of follow-up, the intel-
ligibility threshold was improved by 25 dB in comparison with the preoperative results with two
hearing aids. The implant worked perfectly well and the child did not show any complication
during this period.
Conclusion: The reliability of the implant and the quality of the auditory results obtained in this
case and in a limited number of cases in the world make the Vibrant Med-El® a new therapeutic
option in hearing loss in children with bilateral auricular atresia.
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IntroductionRehabilitation of permanent deafness in children diagnosed
before the age of 3months with early adaptation of hearing
aids can provide signiﬁcantly better levels of oral language
development [1,2]. In the most frequent cases in which the
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uter ear anatomy is normal, conventional behind-the-ear
mplifying hearing aids are proposed. In cases of bilat-
ral major auricular atresia, the diagnosis of deafness is
uspected at birth. The level of pure or mixed conduc-
ive hearing impairment is quickly conﬁrmed with auditory
voked potentials and infant audiometry. Once the diagno-
is has been made, it is possible to provide these children
ith bone conduction hearing aids. Since 2002, beginning at
he age of 1month, these hearing aids can use the BAHA®
oftband, which, in cases of pure conductive hearing impair-
ent, provides a mean aided threshold of 27± 6 dBHL [3].
.
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Figure 1 Tone audiogram of the right and left ears in air
conduction (AC), bone conduction (BO) before surgery. Postsur-
gical audiogram (1month) in AC of the operated left before
activation of the middle ear implant (MEI).
Figure 2 Free-ﬁeld warble tone audiometry with and without
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mally ventilated tympanic cavities were small in volume
and there was bilateral incudomallear fusion with a nor-
mal descending branch of the incus and normal stapes. The
cochleae, the vestibular aqueducts, and the internal audi-
tory canals showed no morphological deformities (Fig. 4).2
one stimulation with a headband remains an effective
lternative with a mean aided threshold of 25± 6 dBHL, but
earing this device is often uncomfortable because of the
onstant pressure on the head [3]. A BAHA® can be sug-
ested before the age of 6 years, but the possible cutaneous
nd ﬁxture complications are such that during this period
his is not advised [4]. The US Food and Drug Administration
ecommends the BAHA® after 5 years of age.
After 6 years of age, a BAHA® or functional aural surgery
n cases of type I or IIa atresia according to the Cremers’
lassiﬁcation [3] is currently being debated. Beyond these
ituations that are a priori well codiﬁed, the advances of
iddle ear implant (MEI) technologies are opening new per-
pectives for restoring hearing. In 2007, for the ﬁrst time in
rance a team in Lyon implanted such a device in a 14-year-
ld child presenting bilateral auricular atresia in a context
f Franceschetti’s syndrome with the fully implantable Oto-
ogics Carina MEI [5]. Another MEI, the vibrant Med-El®,
xtended its indications in September 2007 to mixed or
onductive deafness in the adult [6] and to children in
une 2009.
The objective of this case study was to report the results
ith more than 18months of follow-up of the ﬁrst implan-
ation in France of a Vibrant Med-El® in a 9-year-old child
ith bilateral auricular atresia.
ase study
he child was 9 years old at the time of implantation and pre-
ented stenosis-type atresia of the external auditory canal
EAC). The diagnosis of hearing loss had been conﬁrmed at
he age of 1.5 years with an early auditory evoked poten-
ial (EAEP) study (right and left ear threshold, 70 dB) in
ccordance with the infant audiometry study. Conventional
mplifying hearing aids were initiated 1month after diag-
osis. A bone conduction hearing aid with a headband was
uggested but refused by the family. In the child’s neonatal
istory, there had been septicemia following vesicourethral
eﬂux. A pyelocaliceal malformation required corrective
urgery. Karyotype genetic testing identiﬁed monosomy 18.
his child received initial orthophonic and psychomotor
are. He then attended preschool and primary school in an
nclusion class for disabled children with multidisciplinary
are including orthophonic and psychomotor work, psycho-
ogical support, and special education. For 7 years, hearing
ids were worn regularly despite the recurrent Larsen-
ffect problems and the many absences because of recurring
pisodes of eczema in both EACs.
The child consulted in 2007 enquiring about the
ossibilities of hearing restoration. The results of the pre-
perative exams were as follows.
Functional auditory testing showed bilateral nonevolving
ype II intermediate mixed symmetrical deafness. The mean
ir conduction thresholds (measured at 500, 1000, 2000, and
000Hz) were 65 dB on the right and 60 dB on the left. The
ean bone conduction thresholds were 23.75 dB on the right
nd left (Fig. 1). The mean aided thresholds measured with
arble tones were 43.75 dB for a mean overall aided gain of
3 dB (Fig. 2). The intelligibility thresholds evaluated based
n the Lafon French standardized children’s disyllabic word
ists were 70 dB on the right and 65 dB on the left for air
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sonventional hearing aid before surgery (AP*2). Results of aided
hresholds obtained after 1, 12, and 18months, respectively, of
iddle ear implant (MEI) wear.
onduction and 35 dB on the right and 30 dB on the left for
one conduction. The aided intelligibility thresholds with
wo hearing aides were at 55 dB (Fig. 3). The electrophysio-
ogical thresholds obtained with auditory evoked potentials
f the brainstem were 60 dB on both the right and left.
The CT scan of the petrosal bone showed recessed EACs
ith no differentiation of the tympanic membrane. The nor-igure 3 Intensity intelligibility threshold obtained of 100%
ntelligibility in bone conduction, with both conventional hear-
ng aids before surgery (AP*2) and at 1, 12, and 18months after
urgery with the Vibrant Med-El®.
Middle ear implant for mixed hearing loss with malformation in a
Figure 4 Preoperative axial CT of the petrosal bone showing
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sincudomallear fusion on the right and left, pneumatization of
the mastoids, the deformity of the two external auditory canals
(EAC), and the normal aspect of the inner ear components.
The therapeutic options proposed to the parents and the
child included functional ossiculoplasty surgery with meato-
plasty or BAHA® or a Vibrant Med-El® implant.
The third option, the MEI Vibrant Med-El® implant, was
retained after informing the parents on the risks involved
(i.e., VIIth nerve injury, cochlear risk, the possibility that
implant ﬁxation would not be achievable, and unknown
results in children) and acceptance by the parents and the
child.
The surgery proceeded via a posterior approach with a
retroauricular incision. The musculoperiosteal ﬂap was cut
and the periosteum was elevated from the mastoid process,
thus creating a pocket. After a canal wall-up mastoidectomy,
a posterior tympanotomy was performed. Despite the small
size of the tympanic cavity, the malleus and the incus were
cleared and the ﬂoat mass transducer was clipped onto the
long process of the uncus, which had a reduced mobility.
The child left the unit 2 days after the surgery and the
implant was activated 2weeks later using a No.2 magnet.
Cutaneous healing was perfect with no sign of irritation. No
modiﬁcation of cochlear function was noted and the device
was set, with immediate results. The child’s ﬁrst reaction
was surprise once audition had become clear, without the
disadvantage of the EAC occlusion.
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After 1month of experience with the implant, the mean
ided thresholds at conversational frequencies were 37.5 dB
ith 100% vocal intelligibility at 50 dB with the Lafon French
tandardized children’s disyllabic word lists (Fig. 3).
After 12months of wear, the device was set again. The
ided thresholds remained stable at 37.5 dB with a slight
mprovement in vocal intelligibility: 100% at 45 dB (Fig. 3).
he child wore the implant continuously and had abandoned
he contralateral hearing aid. Reliability was perfect.
After 18months of wear, the device was readjusted. The
ided thresholds improved to 33.75 dB, as did vocal intelli-
ibility: 100% at 40 dB (Fig. 3). The mean aided tone gain
as 23.75 dB. The child wears the implant continuously.
eliability is perfect. During the last adjustment, the child
equested a contralateral MEI.
iscussion
his ﬁrst French experience of a Med-El® MEI in a 9-year-
ld child with the purpose of correcting mixed congenital
eafness conﬁrmed the feasibility of this technique for this
ndication.
After 18months of follow-up, this technique has demon-
trated its stability and reliability. The child had undergone
o repair of the external processor and the adjustments of
he processor were proposed systematically every 6months.
he adjustments were minimal each time. The results in
erms of auditory perception were deemed perfect by the
hild and his family with the request for bilateral implan-
ation because the contralateral hearing aid had been
bandoned, which was appropriate because of the audi-
ory asymmetry, the new hearing quality, the comfort of the
bsence of EAC occlusion, as well as the recurring problems
f eczema on the side aided by the classic hearing aid.
In this type of clinical presentation, other therapeutic
ptions, including functional surgery with meatoplasty and
ssiculoplasty and BAHA® were discussed with the parents
nd the child.
The Cremers’ classiﬁcation of congenital auricular atre-
ia [3] distinguishes four types. In type I, the tympanic
embrane is present but hypoplastic. Type IIa consists in
artial atresia of the EAC, whereas type IIb is full atresia.
n type III, atresia of the EAC is full, with malformation of
he tympanic cavity. According to Cremers et al., recon-
tructive surgery of the EAC is not possible in types I and IIa
3]. In our clinical case, the malformation was type I or IIa,
hich therefore required analyzing the functional results as
ell as the follow-up and potential complications, notably
eatoplasty. Studies have shown the surgical possibilities of
analoplasty, with their results summarized in the study by
vans and Kazahaya [7]. The prerequisite to any analysis is
o deﬁne the criteria for audiometric success in relation to
he schoolchild’s needs in terms of auditory perception. The
erception threshold should be 15 dB HL or less if the bone
onduction is normal or at the level of bone conduction if
ensory participation has been added [7]. According to this
ame study, in cases of auditory canal reconstruction, the
ean gain in audition was 17.3 dB and more than 93% of
he subjects needed complementary auditory ampliﬁcation.
ate complications such as stenosis recurrence, recurrent
xternal otitis, and cholesteatoma were noted. The conclu-
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ions favored BAHA® as regards the quality of the functional
esults at the short-, intermediate-, and long-terms, with
mean gain in hearing of 31.8 dB. In our clinical case, no
omplication was noted in 18months and the intelligibil-
ty obtained with the Vibrant Med-El® was equivalent if not
lightly better than in direct bone conduction.
BAHA® ‘‘guarantees’’ the functional results, which
xplains its priority indication in the majority of congenital
uricular atresia cases. However, the esthetic aspect, the
sychological apprehension for a transcutaneous implant,
he risks of local inﬂammation, and the consequent need for
aily local hygiene makes some parents reluctant to choose
his option.
The indication for the Vibrant Med-El® in mixed deafness
nd adult conduction made this option possible in the clini-
al case reported herein. According to the study conducted
y Coletti et al., there exist different vibroplasty tech-
iques in relation with the ossicular anatomy encountered
8]. Notably, the Float Mass Transducer can be placed in the
ound window. The stability of this technique’s long-term
esults have not been clearly established; consequently, in
hildren it is more suitable to favor the surgical technique
iming to attach the FMT to the descending branch of the
ncus or even the stapes, but additional results in adults
ould solidify this indication.
The MEI in children now has its place among the thera-
eutic options for bilateral congenital conductive or mixed
earing loss. This indication has been in the validation phase
or the Vibrant Med-El® since June 2009. The possibilities for
his type of implant continue to be explored. For example,
n 2009 Frenzel et al. [9] reported seven cases of hearing
ehabilitation using the Vibrant Med-El® in cases of unilat-
ral hearing loss stemming from major unilateral aplasia. In
ne case, the FMT was placed on the descending branch of
he incus, in three cases on the stapes, in two cases on the
ase of the stapes, and in two cases in the round window.
he bone curves were unchanged between the pre- and post-
perative phases. The functional results at 8months were
3.8 dB HL for the mean aided thresholds, for a mean aided
ain of 45.5 dB HL. Aided intelligibility was 64% at 50 dB.
[S. Roman et al.
The therapeutic options for congenital bilateral mixed
r conductive deafness due to auricular atresia in children
hould be discussed in light of this clinical case. Perspectives
ill undoubtedly open up in the management of this type of
nilateral hearing loss in the near future.
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